Cefotaxime

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

39 Suppliers, 14 USDMF, 16 CEP/COS, 1 JDMF, 6 EU WC, 7 KDMF, 1 NDC API, 21 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

205 Dossiers, 40 FDA Orange Book, 56 Europe, 2 Canada, 2 Australia, 25 South Africa, 80 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 38 Finished Drug Prices

MARKET PLACE

19 APIs, 10 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

3 EDQM Standards, 2 USP Standards, 2 Other Ref. Standards

DIGITAL CONTENT

6 News

6 News

List of USP reference standards related to Cefotaxime

Cefotaxime

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

39 Suppliers

14 USDMF

16 CEP/COS

1 JDMF

6 EU WC

7 KDMF

1 NDC API

21 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

205 Dossiers

40 FDA Orange Book

56 Europe

2 Canada

2 Australia

25 South Africa

80 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions

38 Finished Drug Prices

MARKET PLACE

19 APIs

10 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

3 EDQM Standards

2 USP Standards

2 Other Ref. Standards

DIGITAL CONTENT

6 News

Cefotaxime

USP

Cefotaxime Related Compound E (15 mg) ((Z)-2-(2-aminoth...

1097953

66340-33-8

F01110

805

USP

Cefotaxime Sodium (500 mg)

1097909

64485-93-4

R071G0

R021H0 (30-JUN-2018)

230

INJECTABLE;INJECTION - EQ 10GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons